NASDAQ:KTTA

Pasithea Therapeutics Corp.

Stock

USD

Last Close

4.56

26/07 20:00

Market Cap

5.45M

Beta: -

Volume Today

2.75K

Avg: 58.36K

PE Ratio

−0.56

PFCF: −0.43

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '20	Dec '21	Dec '22	Dec '23
net income	-40.98K -	-2.17M 5,203.34%	-13.94M 541.19%	-15.51M 11.27%
depreciation and amortization		1.38K -	32.37K 2,247.64%	648.45K 1,903.01%
deferred income tax		-2.33M -		-1.07B -
stock based compensation		471.25K -	552.82K 17.31%	592.27M 107,035.38%
change in working capital	2.29K -	111.23K 4,746.80%	-138.44K 224.46%	1.57M 1,237.10%
accounts receivables
inventory
accounts payables		440.68K -	831.64M 188,618.72%	1.07B 28.78%
other working capital	2.29K -	-329.44K 14,454.81%	-831.78M 252,380.23%	-1.07B 28.57%
other non cash items		750K -	-1.07M 242.96%	478.56M 44,732.13%
net cash provided by operating activities	-38.69K -	-3.17M 8,104.03%	-14.56M 358.78%	-13.43M 7.80%
investments in property plant and equipment		-21.50K -	-2.14M 9,845.62%	-34.30K 98.40%
acquisitions net			77.06K -	109.50K 42.10%
purchases of investments
sales maturities of investments
other investing activites				323.81K -
net cash used for investing activites		-21.50K -	-2.06M 9,487.25%	399.01K 119.35%
debt repayment
common stock issued	282.34K -	50.24M 17,693.00%
common stock repurchased			-3.21M -	-3.73M 16.22%
dividends paid
other financing activites	423.51K -	5.69M 1,244.15%
net cash used provided by financing activities	282.34K -	55.93M 19,709.23%	-3.21M 105.73%	-3.73M 16.22%
effect of forex changes on cash		-10.56K -	9.90K 193.74%	-291.46M 2,944,160.61%
net change in cash	243.65K -	52.72M 21,538.85%	-19.82M 137.59%	-16.76M 15.45%
cash at beginning of period		243.65K -	52.97M 21,638.85%	33.09M 37.53%
cash at end of period	243.65K -	52.97M 21,638.85%	33.15M 37.42%	16.33M 50.73%
operating cash flow	-38.69K -	-3.17M 8,104.03%	-14.56M 358.78%	-13.43M 7.80%
capital expenditure		-21.50K -	-2.14M 9,845.62%	-34.30K 98.40%
free cash flow	-38.69K -	-3.20M 8,159.61%	-16.70M 422.62%	-13.46M 19.41%

All numbers in USD (except ratios and percentages)